Anticoagulation Strategies in the Perioperative Period for Lung Transplant

Ann Thorac Surg. 2020 Jul;110(1):e23-e25. doi: 10.1016/j.athoracsur.2019.11.056. Epub 2020 Jan 22.

Abstract

Patients who are undergoing lung transplantation may require systemic anticoagulation in the perioperative period for various indications at the time of the procedure. Four-factor prothrombin complex concentrate has been approved in the United States to reverse the effects of warfarin for patients requiring urgent surgery. We describe a perioperative anticoagulation strategy with warfarin that is reversed before incision using 4-factor complex concentrate for off-pump lung transplant recipients.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Blood Coagulation / drug effects
  • Blood Coagulation Factors / therapeutic use*
  • Humans
  • Lung Transplantation*
  • Perioperative Care / methods*
  • Thrombosis / prevention & control*
  • Transplant Recipients*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Blood Coagulation Factors
  • prothrombin complex concentrates
  • Warfarin